Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Table 6 Factors that influence bleeding as side effect by stepwise logistic regression method

Factor	Adjusted ODDS ratio	95% CI	P-value
New users	0.51	0.27–0.91	0.022*
A: Aged 75 or older	1.55	0.87–2.79	0.136
S: Stroke/TIA	1.71	0.94–3.07	0.081
With antiplatelet agents	2.04	1.07–3.75	0.030*

ISSN: 2055-0294